Sudeep Pharma Limited’s Rs 895 crore Initial Public Offering to open on Friday, November 21, 2025 Price band set at Rs 563 – Rs 593 per Equity Share Read more
Pfizer Launches New Rimegepant Oral Medication in India for Rapid Migraine Relief[i] and Acute Treatment Read more
Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg Read more
Alembic Pharmaceuticals Limited announces USFDA Final Approval Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg Read more
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets Read more
Supriya Lifescience’s Ambernath Facility Receives WHO GMP Certification; Paves Way for Formulations Expansion Read more
Glenmark Strengthens Oncology Portfolio with Hengrui’s HER2 Targeting ADC For Multiple Regions Read more
Nation-Wide Study Confirms ChilRun full Accelerates Growth and Development in Children, in just 90 days Read more